Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Strategic Prevention Framework Partnerships for Success
The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Prevention (CSAP), is accepting applications for Fiscal Year (FY) 2018 Improving Access to Overdose Treatment (Short Title:
OD Treatment Access).
SAMHSA will award OD Treatment Access funds to
Federally Qualified Health Centers (FQHC), Opioid Treatment Programs, or practitioners who has a waiver to prescribe buprenorphine to expand access to Food and Drug Administration (FDA)-approved drugs or devices for emergency treatment of known or suspected opioid overdose.
Recipients will partner with other prescribers at the community level to develop best practices for prescribing and co-prescribing FDA-approved overdose reversal drugs.
After developing best practices, the recipients will train other prescribers in key community sectors as well as individuals who support persons at high risk for overdose In 2013, SAMHSA released the Opioid Overdose Prevention Toolkit to help reduce the number of opioid-related overdose deaths and adverse events.
The OD Treatment Access grant program will utilize this toolkit and other resources to help the recipient train and provide resources for health care providers and pharmacists on the prescribing of drugs or devices approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose The OD Treatment Access grant program will also ensure the recipient establishes protocols to connect patients who have experienced a drug overdose with appropriate treatment, including medication-assisted treatment and appropriate counseling and behavioral therapies.
OD Treatment Access).
SAMHSA will award OD Treatment Access funds to
Federally Qualified Health Centers (FQHC), Opioid Treatment Programs, or practitioners who has a waiver to prescribe buprenorphine to expand access to Food and Drug Administration (FDA)-approved drugs or devices for emergency treatment of known or suspected opioid overdose.
Recipients will partner with other prescribers at the community level to develop best practices for prescribing and co-prescribing FDA-approved overdose reversal drugs.
After developing best practices, the recipients will train other prescribers in key community sectors as well as individuals who support persons at high risk for overdose In 2013, SAMHSA released the Opioid Overdose Prevention Toolkit to help reduce the number of opioid-related overdose deaths and adverse events.
The OD Treatment Access grant program will utilize this toolkit and other resources to help the recipient train and provide resources for health care providers and pharmacists on the prescribing of drugs or devices approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose The OD Treatment Access grant program will also ensure the recipient establishes protocols to connect patients who have experienced a drug overdose with appropriate treatment, including medication-assisted treatment and appropriate counseling and behavioral therapies.
Related Programs
Substance Abuse and Mental Health Services_Projects of Regional and National Significance
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Substance Abuse and Mental Health Services Adminis
Estimated Funding: $940,000
Office: Substance Abuse and Mental Health Services Adminis
Estimated Funding: $940,000
Who's Eligible
Obtain Full Opportunity Text:
OD Treatment Access
Additional Information of Eligibility:
SAMHSA is limiting eligibility to FQHCs (as defined in section 1861(aa) of the Social Security Act), opioid treatment programs (as defined under part 8 of title 42, Code of Federal Regulations), and practitioners dispensing narcotic drugs (pursuant to section 303(g) of the Controlled Substances Act).
Eligibility Explanation: The eligibility for this grant program is statutorily defined in Section 544 of the Public Health Service Act.
Recipients who received funding under SP-17-006 are not eligible to apply.
Full Opportunity Web Address:
http://www.samhsa.gov/grants/grant-announcements/sp-18-006
Contact:
Agency Email Description:
FOACSAP@samhsa.hhs.gov
Agency Email:
Date Posted:
2018-04-05
Application Due Date:
Archive Date:
2018-07-04
Social Entrepreneurship
Spotlight
Why People Buy from Social Enterprises?
The Guardian has compiled a list of responses to its latest open thread, and has announced the winner of the social enterprise gift hamper packed with presents.
Learn How to Identify and Avoid Grant Scams
